SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Semler Scientific, Inc. (NASDAQ: SMLR) securities between March 10, 2021 and April 15, 2025. Semler Scientific describes itself as a company that develops and markets technology products and services that assist its customers in evaluating and treating chronic diseases.
For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.
The Allegations: Robbins LLP is Investigating Allegations that Semler Scientific, Inc. (SMLR) Failed to Disclose it Was Being Investigated for Violations of the False Claims Act
According to the complaint, during the class period, defendants failed to disclose a material investigation by the United States Department of Justice into violations of the False Claims Act, while discussing possible violations of the False Claims Act (and aggressive DOJ enforcement thereof) in hypothetical terms.
Plaintiff alleges that on February 28, 2025, Semler Scientific first revealed that in July 2017, it had "received an initial civil investigative demand ("CID") from the U.S. Department of Justice ("DOJ") pursuant to the federal False Claims Act investigating whether the Company and others may have violated the False Claims Act by marketing tests on devices that use photoplethysmography technology as reimbursable by Medicare in alleged...
Vingroup has filed civil lawsuits, reported to authorities, and sent notices to embassies regarding 68 organisations and individuals accused of spreading false information about the group online. A...